Figure 2 | Scientific Reports

Figure 2

From: Coagulation potential and the integrated omics of extracellular vesicles from COVID-19 positive patient plasma

Figure 2

Flow-cytometry analysis of EVs: (A) Distribution of CD63, CD81 and CD62P markers in healthy donor (left panel) and COVID-19 (+) patients (right panel) SEVs and LEVs. (B) Comparison of CD41, CD235a, and CD31 distribution between COVID-19 (+) patients SEVs and LEVs (top panel) (C) healthy donor and COVID-19 (+) patients SEVs (middle panel) (D) healthy donor and COVID-19 (+) patients LEVs (bottom panel). (E) Annexin V staining between COVID-19 (+) patients SEVs and LEVs (left panel) healthy and COVID-19(+) patients SEVs (middle panel), healthy donor and COVID-19 (+) patients LEVs (right panel). n = 6 each of healthy and COVID-19 SEVs and LEVs used Flow-cytometric characterization.

Back to article page